The Anti-Radiation Drugs Market is expanding as governments, defense agencies, oncology centers, and pharmaceutical developers prioritize medical countermeasures that mitigate cellular damage from ionizing radiation. Growth is supported by rising cancer radiotherapy volumes, heightened geopolitical and nuclear safety preparedness, national emergency stockpiling programs, and advancements in...
The Progesterone Market is expanding as pharmaceutical manufacturers, fertility clinics, healthcare providers, and women's health networks scale up treatments for reproductive disorders, assisted reproductive technology (ART), and menopausal care. Growth is supported by rising infertility rates, expanding in-vitro fertilization (IVF) procedures, greater adoption of hormone replacement therapy...
US Stomach Cancer Market expansion is encouraged by substantial pharmaceutical research activity and clinical trial investments. Research organizations and drug developers are investigating novel treatment candidates to address unmet needs in gastric cancer care.
The stomach cancer market is expected to reach US$ 12,541 million by 2031, registering a CAGR of 14.9% during the forecast period...
North America Lymphoma Treatment Market growth is also supported by the presence of specialized cancer hospitals and established oncology distribution networks. These facilities help deliver complex medicines and coordinate treatment, monitoring, and supportive care for lymphoma patients.
The Lymphoma Treatment Market size is expected to reach US$ 2.67 billion by 2034 from US$ 1.71 billion in...
The Global Genomics Market is experiencing substantial growth as advances in genetic research, sequencing technologies, and molecular diagnostics transform healthcare and life sciences. Genomics involves the study of an organism’s complete DNA, including the interactions and functions of genes. Its applications span disease diagnosis, personalized medicine, drug discovery, agricultural...
The HDAC Inhibitor Market is gaining attention as pharmaceutical companies increasingly explore epigenetic therapies for cancer and other complex diseases. Histone deacetylase inhibitors regulate gene expression by blocking HDAC enzymes, influencing cellular processes such as differentiation, proliferation, and apoptosis. Their therapeutic potential is supporting continued research and...
Drug carriers that the body can absorb are gaining attention. It is one reason the Bioresorbable Polymers Market is rising from US$ 4.86 billion in 2025 to US$ 11.94 billion by 2034. The expected CAGR is 10.5% from 2026 to 2034.
What Is Driving the Market?
The first driver is the wish to avoid repeat surgery. Bioresorbable polymers break down into non-toxic by-products such as carbon dioxide...
The global Cell and Gene Therapy Market is expanding as pharmaceutical and biotechnology companies increase their focus on advanced treatments for chronic diseases, genetic disorders, oncology, rare diseases, and personalized medicine. Increasing research activity, biotechnology investments, regulatory support, and technological innovation are contributing to the development and adoption of...
"According to the latest report published by Data Bridge Market Research, the Primary Mediastinal Large B-cell Lymphoma Treatment Market
CAGR Value
The global primary mediastinal large B-cell lymphoma treatment market size was valued at USD 850.00 million in 2025 and is expected to reach USD 1,354.77 million by 2033, at a CAGR of 6.00% during the forecast period...
The global Genetic Engineering Market is experiencing strong expansion as advances in gene editing technologies, increasing chronic disease prevalence, and changing healthcare needs create new opportunities across biotechnology and life sciences.
The Genetic Engineering Market was valued at 3982.57 million in 2024 and is expected to reach 9196.67 million by 2031. The market is anticipated to...
Polaris Market Research has published its latest research report titled Prostate Cancer Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Others); By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies); By Region; Segment Forecast, 2026 - 2034. The report...
Polaris Market Research has published its latest research report titled Prostate Cancer Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Others); By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies); By Region; Segment Forecast, 2026 - 2034. The report...